---
figid: PMC7242206__gr2_lrg
figtitle: Possible targets of the androgen pathway for severe acute respiratory syndrome
  coronavirus 2 (SARS-CoV-2) prophylaxis and adjuvant therapy
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC7242206
filename: gr2_lrg.jpg
figlink: pmc/articles/PMC7242206/figure/fig2/
number: F2
caption: Possible targets of the androgen pathway for severe acute respiratory syndrome
  coronavirus 2 (SARS-CoV-2) prophylaxis and adjuvant therapy. Antiandrogen therapies
  include gonadotropin-releasing hormone (GnRH) analogs (degarelix, goserelin, leuprolide,
  leuprorelin, nafarelin), which stop luteinizing hormone (LH) secretion and induce
  chemical castration. Testosterone is regarded as the main androgen hormone, and
  its production is inhibited by ketoconazole, an inhibitor of steroidogenesis. Dutasteride
  and finasteride, 5-α-reductase inhibitors, target synthesis of dihydrotestosterone,
  the most potent intrinsic androgen hormone. Androgen receptor inhibitors may be
  steroidal (abiraterone, cyproterone, nomegestrol, or spironolactone), or nonsteroidal
  (apalutamide, bicalutamide, darolutamide, enzalutamide, flutamide, or nilutamide).
  Transmembrane protease, serine 2 (TMPRSS2) blockers include bromhexine, camostat,
  and nafamostat. ACE, Angiotensin converting enzyme.
papertitle: 'Androgenetic alopecia present in the majority of patients hospitalized
  with COVID-19: The “Gabrin sign”.'
reftext: Carlos Gustavo Wambier, et al. J Am Acad Dermatol. 2020 Aug;83(2):680-682.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9596133
figid_alias: PMC7242206__F2
figtype: Figure
redirect_from: /figures/PMC7242206__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7242206__gr2_lrg.html
  '@type': Dataset
  description: Possible targets of the androgen pathway for severe acute respiratory
    syndrome coronavirus 2 (SARS-CoV-2) prophylaxis and adjuvant therapy. Antiandrogen
    therapies include gonadotropin-releasing hormone (GnRH) analogs (degarelix, goserelin,
    leuprolide, leuprorelin, nafarelin), which stop luteinizing hormone (LH) secretion
    and induce chemical castration. Testosterone is regarded as the main androgen
    hormone, and its production is inhibited by ketoconazole, an inhibitor of steroidogenesis.
    Dutasteride and finasteride, 5-α-reductase inhibitors, target synthesis of dihydrotestosterone,
    the most potent intrinsic androgen hormone. Androgen receptor inhibitors may be
    steroidal (abiraterone, cyproterone, nomegestrol, or spironolactone), or nonsteroidal
    (apalutamide, bicalutamide, darolutamide, enzalutamide, flutamide, or nilutamide).
    Transmembrane protease, serine 2 (TMPRSS2) blockers include bromhexine, camostat,
    and nafamostat. ACE, Angiotensin converting enzyme.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - kita
  - ngfra
  - ar
  - ace2
  - ace
  - fgf8a
  - tmprss2
  - CGA
  - LHB
  - AR
  - ACE2
  - ACE
  - TMPRSS2
  - Leuprolide
  - Ketoconazole Leuprorelin
  - Nafarelin
  - Dutasteride
  - Testosterone
  - Androgen
  - 5-alpha
  - Apalutamide
  - Bicalutamide
  - Darolutamide
  - Enzalutamide
  - Dihydrotestosterone
  - Abiraterone
  - Cyproterone
  - Spironolactone
  - Nilutamide
  - Bromhexine
  - Nafamostat
  - SARS-CoV -2
---
